657 results Stibbe assists Goed Stibbe successfully assisted Goed on the sale of its pharmaceutical retail and wholesale business to Multipharma. Roos Elemans included in Women in Antitrust 2025 guide Roos Elemans, lawyer and partner in Stibbe’s EU and Competition practice in Amsterdam, has been included in Global Competition Review’s Women in Antitrust 2025 guide. Rogier Raas Partner Amsterdam EU merger guidelines review: catching up with the times? A potential major overhaul of EU merger control review began on 8 May 2025. Time for stakeholders to speak up about whether and particularly how the European Commission should incorporate wider strategic or societal objectives into its merger assessments. Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment. Kroniek van het mededingingsrecht Wat de gevolgen van de coronacrisis zullen zijn voor de samenleving, de economie en – laat staan – het mededingingsbeleid laat zich op het moment van de totstandkoming van deze kroniek niet voorspellen. Shaping the Future: The Belgian Competition Authority’s 2025 Roadmap On 29 April 2025, the Belgian Competition Authority announced its sectoral and strategic priorities. These priorities reflect a confident authority that seeks to strengthen its enforcement tools to meet new challenges in competition law. Employers beware: the Commission joins the ‘labour party’ Companies should review their recruitment and hiring policies and practices. The Commission has joined the hunt for ‘job cartels’ with its first ever cartel in the labour market. Stibbe advises Aedifica on agreement with Cofinimmo to form Europe’s leading healthcare REIT Stibbe advised Aedifica on its proposed conditional exchange offer to Cofinimmo and the resulting agreement to combine and create Europe’s leading healthcare REIT. No time to rest! Updates on Dutch and European investment screening After a busy 2024 in terms of screening action, there is no time to take a rest for the Dutch and EU legislators on the topic of investment screening. Time for another update! Say cheese! Are your distribution agreements picture-perfect? Suppliers and distributors should double-check their agreements. The European Court of Justice has provided guidance for the assessment of exclusive distribution agreements. Stibbe defends EY in a class action re Airbus Stibbe defends EY in a class action on misrepresentations allegedly made by Airbus in connection with asserted irregularities for which Airbus entered into settlements with criminal justice authorities in France, the UK and the US in 2020. Buy the dip! Toezicht en handhaving op finfluencers In een nieuwe aflevering van onze podcast Stibbe Legal Insights duiken we in de wereld van finfluencers: online persoonlijkheden die beleggingsadvies geven of financiële producten aanprijzen via social media. Joost van 't Hof Junior Associate Amsterdam Cross-border corporate lending into the Netherlands Cross-border corporate lending is set for change as CRD VI introduces new licensing obligations, requiring non-EU lenders to reassess their activities in the Netherlands and the EU for all in scope contracts signed on or after 11 July 2026. European Commission Updates High-Risk Third Countries List The European Commission adopted a Delegated Regulation (EU/2025/1184) amending its list of high-risk third countries under the Anti-Money Laundering and Anti-Terrorism Financing Directive. The Netherlands Implements EU Non-Performing Loan Directive The Dutch Implementation Act on Credit Servicers and Credit Purchasers entered into force on 18 July 2025. It implements EU Directive 2021/2167 regulating NPL sale, purchase and servicing to create a transparent secondary market. Jeroen Kortmann Partner Amsterdam Pagination Previous page Page 34 Page 35 Current page 36 Page 37 Next page
Stibbe assists Goed Stibbe successfully assisted Goed on the sale of its pharmaceutical retail and wholesale business to Multipharma.
Roos Elemans included in Women in Antitrust 2025 guide Roos Elemans, lawyer and partner in Stibbe’s EU and Competition practice in Amsterdam, has been included in Global Competition Review’s Women in Antitrust 2025 guide.
EU merger guidelines review: catching up with the times? A potential major overhaul of EU merger control review began on 8 May 2025. Time for stakeholders to speak up about whether and particularly how the European Commission should incorporate wider strategic or societal objectives into its merger assessments.
Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment.
Kroniek van het mededingingsrecht Wat de gevolgen van de coronacrisis zullen zijn voor de samenleving, de economie en – laat staan – het mededingingsbeleid laat zich op het moment van de totstandkoming van deze kroniek niet voorspellen.
Shaping the Future: The Belgian Competition Authority’s 2025 Roadmap On 29 April 2025, the Belgian Competition Authority announced its sectoral and strategic priorities. These priorities reflect a confident authority that seeks to strengthen its enforcement tools to meet new challenges in competition law.
Employers beware: the Commission joins the ‘labour party’ Companies should review their recruitment and hiring policies and practices. The Commission has joined the hunt for ‘job cartels’ with its first ever cartel in the labour market.
Stibbe advises Aedifica on agreement with Cofinimmo to form Europe’s leading healthcare REIT Stibbe advised Aedifica on its proposed conditional exchange offer to Cofinimmo and the resulting agreement to combine and create Europe’s leading healthcare REIT.
No time to rest! Updates on Dutch and European investment screening After a busy 2024 in terms of screening action, there is no time to take a rest for the Dutch and EU legislators on the topic of investment screening. Time for another update!
Say cheese! Are your distribution agreements picture-perfect? Suppliers and distributors should double-check their agreements. The European Court of Justice has provided guidance for the assessment of exclusive distribution agreements.
Stibbe defends EY in a class action re Airbus Stibbe defends EY in a class action on misrepresentations allegedly made by Airbus in connection with asserted irregularities for which Airbus entered into settlements with criminal justice authorities in France, the UK and the US in 2020.
Buy the dip! Toezicht en handhaving op finfluencers In een nieuwe aflevering van onze podcast Stibbe Legal Insights duiken we in de wereld van finfluencers: online persoonlijkheden die beleggingsadvies geven of financiële producten aanprijzen via social media.
Cross-border corporate lending into the Netherlands Cross-border corporate lending is set for change as CRD VI introduces new licensing obligations, requiring non-EU lenders to reassess their activities in the Netherlands and the EU for all in scope contracts signed on or after 11 July 2026.
European Commission Updates High-Risk Third Countries List The European Commission adopted a Delegated Regulation (EU/2025/1184) amending its list of high-risk third countries under the Anti-Money Laundering and Anti-Terrorism Financing Directive.
The Netherlands Implements EU Non-Performing Loan Directive The Dutch Implementation Act on Credit Servicers and Credit Purchasers entered into force on 18 July 2025. It implements EU Directive 2021/2167 regulating NPL sale, purchase and servicing to create a transparent secondary market.